Doraya catheter for Heart Failure

Henry Ford, Detroit, MI
Heart FailureDoraya catheter - Device
Eligibility
18 - 85
All Sexes

Study Summary

This trial is testing a new type of catheter to see if it is safe and effective for people with heart failure who haven't responded well to other treatments.

Eligible Conditions
  • Acute Heart Failure

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Bendroflumethiazide/ Amiloride
1
Bumetanide 1.25 mg
1
Protocolized spot urine sodium guided diuretic therapy

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: baseline [pre intervention] and accumulated through 24 hours [T=0-24 hours]

30 days
Serious Adverse Events
Hour 24
Urine Output

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Bendroflumethiazide/ Amiloride
1
Bumetanide 1.25 mg
2
Protocolized spot urine sodium guided diuretic therapy

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

ADHF patients
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Doraya catheter · No Placebo Group · N/A

ADHF patients
Device
Experimental Group · 1 Intervention: Doraya catheter · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Doraya catheter
2018
N/A
~10

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline [pre intervention] and accumulated through 24 hours [t=0-24 hours]

Who is running the clinical trial?

Revamp Medical Inc.Lead Sponsor

Eligibility Criteria

Age 18 - 85 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are individuals over the age of 35 eligible to participate in this scientific experiment?

"As per the requirements, only those aged 18 and over but below 85 are eligible to take part in this medical experiment." - Anonymous Online Contributor

Unverified Answer

What is the aggregate size of this medical experiment's cohort?

"Affirmative. Clinicaltrials.gov attests to this medical trial being open for recruitment, which began on May 23rd 2022 and has been refreshed as recently as July 10th 2022. There is a need to identify 15 participants from 5 different sites." - Anonymous Online Contributor

Unverified Answer

Is this research endeavor actively accepting participants?

"Affirmative. According to the materials on clinicaltrials.gov, this medical trial posted in May of 2022 is actively recruiting participants. All together, 15 people need to be enrolled from 5 distinct sites." - Anonymous Online Contributor

Unverified Answer

Which demographics are most advantageous for this clinical trial?

"Applicants aged 18 to 85 suffering from acute decompensated heart failure (ADHF) are welcome to join this medical trial. Candidates must also meet the following prerequisites: a hospitalisation with ADFH as primary diagnosis, NT-proBNP or BNP levels of at least 1600 pg/m and 400pg/mL respectively, clear signs of fluid overload, and an insufficient reaction to IV diuretics." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top